Abstract
The objective of this study was to assess the frequency of blood-brain barrier (BBB) impairment, as measured by the albumin ratio, in neuro-asymptomatic HIV-1-infected individuals without antiretroviral treatment and the correlation between BBB disruption and intrathecal immune activation and HIV-1 RNA levels. Serum and cerebrospinal fluid (CSF) albumin, neopterin, and HIV-1 RNA levels were analysed in 110 neuro-asymptomatic HIV-1-infected individuals at different stages of disease; 63 classified as CDC A, 25 as CDC B, and 22 as CDC C. Increased BBB permeability was found in 17 of 110 (15%) of HIV-1-infected individuals. This proportion was sustained throughout the CDC stages. The albumin ratio was correlated with the CSF neopterin levels (rs = 0.36, P < 0.001), the serum neopterin levels (rs = 0.37, P < 0.001), and the CSF HIV-1 RNA levels (rs = 0.26, P < 0.01), but not with the plasma HIV-1 RNA levels. The correlations between the albumin ratio and the CSF and serum neopterin concentrations and the CSF HIV-1 RNA levels indicate that immune activation and, possibly, intrathecal HIV-1 virus replication are important factors associated with increased BBB permeability in HIV-1 infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
An SF, Groves M, Giometto B, Beckett AA, Scaravilli F (1999). Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol (Berl) 98: 481–487.
Andersson L, Blennow K, Fuchs D, Svennerholm B, Gisslen M (1999). Increased cerebrospinal fluid protein tau concentration in neuro-AIDS. J Neurol Sci 171: 92–96.
Andersson LM, Fredman P, Lekman A, Rosengren L, Gisslen M (1998). Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection. AIDS Res Hum Retroviruses 14: 1065–1069.
Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, Skoog I, Svennerholm L, Wikkelso C (1993). Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18–88 years of age. Eur Neurol 33: 129–133.
Boven LA, Middel J, Verhoef J, De Groot CJ, Nottet HS (2000). Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia. Neuropathol Appl Neurobiol 26: 356–360.
Brew BJ, Dunbar N, Pemberton L, Kaldor J (1996). Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. J Infect Dis 174: 294–298.
Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, Schwartz MK, Price RW (1990). Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 28: 556–560.
Budka H (1991). Neuropathology of human immunodeficiency virus infection. Brain Pathol 1: 163–175.
Chiodi F, Sonnerborg A, Albert J, Gaines H, Norkrans G, Hagberg L, Asjo B, Strannegard O, Fenyo EM (1988). Human immunodeficiency virus infection of the brain. I. Virus isolation and detection of HIV specific antibodies in the cerebrospinal fluid of patients with varying clinical conditions. J Neurol Sci 85: 245–257.
Coombs RW, Henrard DR, Mehaffey WF, Gibson J, Eggert E, Quinn TC, Phillips J (1993). Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol 31: 1980–1986.
Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL (1999). Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1915–1927.
Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736–1739.
Foudraine NA, Hoetelmans RM, Lange JM, de Wolf F, van Benthem BH, Maas JJ, Keet IP, Portegies P (1998). Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 351: 1547–1551.
Fuchs D, Chiodi F, Albert J, Asjo B, Hagberg L, Hausen A, Norkrans G, Reibnegger G, Werner ER, Wachter H (1989). Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. AIDS 3: 285–288.
Furukawa Y, Nishi K, Kondo T, Tanabe K, Mizuno Y (1992). Significance of CSF total neopterin and biopterin in inflammatory neurological diseases. J Neurol Sci 111: 65–72.
Gisslen M, Fuchs D, Svennerholm B, Hagberg L (1999). Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr 21: 271–276.
Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D (1993). Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis 168: 1285–1288.
Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J (1996). Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 10: 167–173.
Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, Hirano A, Dickson DW (1991). Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 22: 700–710.
Marshall DW, Brey RL, Butzin CA, Lucey DR, Abbadessa SM, Boswell RN (1991). CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel. J Acquir Immune Defic Syndr 4: 777–781.
Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN (1988). Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 45: 954–958.
Martin C, Albert J, Hansson P, Pehrsson P, Link H, Sonnerborg A (1998). Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. J Acquir Immune Defic Syndr Hum Retrovirol 17: 214–219.
McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 42: 689–698.
McArthur JC, Nance-Sproson TE, Griffin DE, Hoover D, Scines OA, Miller EN, Margolick JB, Cohen BA, Farzadegan H, Saah A (1992). The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology 42: 1707–1712.
MMWR (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41: 1–19.
Navia BA, Cho ES, Petito CK, Price RW (1986). The AIDS dementia complex: II. Neuropathology. Ann Neurol 19: 525–535.
Persidsky Y, Zheng J, Miller D, Gendelman HE (2000). Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68: 413–422.
Petito CK, Cash KS (1992). Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 32: 658–666.
Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34: 339–350.
Schacker T, Collier AC, Hughes J, Shea T, Corey L (1996). Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125: 257–264.
Sebire K, McGavin K, Land S, Middleton T, Birch C (1998). Stability of human immunodeficiency virus RNA in blood specimens as measured by a commercial PCR-based assay. J Clin Microbiol 36: 493–498.
Sonnerborg AB, von Stedingk LV, Hansson LO, Strannegard OO (1989). Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection. AIDS 3: 277–283.
Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD (1996). Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 39: 705–711.
Tibbling G, Link H, Ohman S (1977). Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37: 385–390.
Trujillo JR, Garcia-Ramos G, Novak IS, Rivera VM, Huerta E, Essex M (1995). Neurologic manifestations of AIDS: a comparative study of two populations from Mexico and the United States. J Acquir Immune Defic Syndr Hum Retrovirol 8: 23–29.
Wiley CA, Achim C (1994). Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 36: 673–676.
Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991). Neocortical damage during HIV infection. Ann Neurol 29: 651–657.
Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83: 7089–7093.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andersson, L.M., Hagberg, L., Fuchs, D. et al. Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals—correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels. Journal of NeuroVirology 7, 542–547 (2001). https://doi.org/10.1080/135502801753248123
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/135502801753248123